X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9861) 9861
Publication (928) 928
Newsletter (263) 263
Book Review (68) 68
Newspaper Article (42) 42
Book / eBook (20) 20
Conference Proceeding (15) 15
Data Set (13) 13
Book Chapter (9) 9
Dissertation (6) 6
Magazine Article (2) 2
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tuberculosis (8569) 8569
humans (7049) 7049
index medicus (6397) 6397
infectious diseases (4750) 4750
female (4346) 4346
male (4233) 4233
adult (3455) 3455
research article (3320) 3320
medicine (3035) 3035
middle aged (2752) 2752
immunology (2607) 2607
infections (2558) 2558
science (2492) 2492
multidisciplinary sciences (2437) 2437
pulmonary tuberculosis (2252) 2252
microbiology (2187) 2187
diagnosis (2082) 2082
research (2050) 2050
hiv (2036) 2036
patients (1929) 1929
health aspects (1835) 1835
human immunodeficiency virus--hiv (1768) 1768
risk factors (1740) 1740
epidemiology (1648) 1648
mycobacterium-tuberculosis (1620) 1620
mycobacterium tuberculosis (1529) 1529
aged (1521) 1521
analysis (1520) 1520
adolescent (1503) 1503
infection (1473) 1473
animals (1465) 1465
studies (1399) 1399
public health (1365) 1365
bacterial diseases (1331) 1331
care and treatment (1314) 1314
mortality (1313) 1313
drug resistance (1302) 1302
young adult (1282) 1282
medical research (1276) 1276
medicine and health sciences (1232) 1232
antitubercular agents - therapeutic use (1194) 1194
disease (1181) 1181
bacteria (1165) 1165
biology and life sciences (1118) 1118
laboratories (1055) 1055
human immunodeficiency virus (1040) 1040
medical diagnosis (1039) 1039
tropical diseases (1024) 1024
biology (1016) 1016
prevalence (1011) 1011
hospitals (994) 994
mice (962) 962
drug therapy (961) 961
aids (952) 952
mycobacterium tuberculosis - isolation & purification (914) 914
tuberculosis - epidemiology (900) 900
antigens (893) 893
proteins (884) 884
cytokines (864) 864
child (860) 860
hiv infections - complications (841) 841
tuberculosis, pulmonary - diagnosis (824) 824
tuberculosis, pulmonary - epidemiology (808) 808
sputum (795) 795
mycobacterium tuberculosis - genetics (782) 782
treatment outcome (779) 779
acquired immune deficiency syndrome--aids (775) 775
vaccines (769) 769
tuberculosis, pulmonary - drug therapy (765) 765
immune response (764) 764
mycobacterium tuberculosis - immunology (761) 761
medicine, experimental (757) 757
immune system (753) 753
genetic aspects (730) 730
respiratory system (726) 726
retrospective studies (715) 715
virology (714) 714
lymphocytes (706) 706
tuberculosis - diagnosis (706) 706
tuberculosis, pulmonary - microbiology (700) 700
tuberculosis - drug therapy (695) 695
children (676) 676
population (671) 671
mycobacterium tuberculosis - drug effects (657) 657
child, preschool (642) 642
usage (639) 639
sputum - microbiology (635) 635
adults (633) 633
incidence (625) 625
immunity (618) 618
lungs (613) 613
tuberculosis - microbiology (599) 599
macrophages (594) 594
lung diseases (591) 591
tuberculosis - immunology (576) 576
diagnostic medicine (575) 575
diagnostic systems (573) 573
pathogens (573) 573
medicine, general & internal (566) 566
organisms (566) 566
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
New College (Ivey) - Stacks (1) 1
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10137) 10137
French (16) 16
Korean (14) 14
Chinese (12) 12
Russian (11) 11
Japanese (5) 5
German (3) 3
Spanish (3) 3
Italian (1) 1
Polish (1) 1
Romanian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, p. e47542
Background: Mortality in the first months of antiretroviral therapy (ART) is a significant clinical problem in sub-Saharan Africa. To date, no post-mortem... 
AUTOPSY | RECONSTITUTION INFLAMMATORY SYNDROME | SUB-SAHARAN AFRICA | TUBERCULOSIS | MULTIDISCIPLINARY SCIENCES | HIV-POSITIVE PATIENTS | DISEASE | ADULTS | COHORT | EARLY MORTALITY | PATHOLOGY | Liver - virology | Tuberculosis, Pulmonary - microbiology | Liver - pathology | Kidney - pathology | Humans | Middle Aged | Male | Tuberculosis, Pulmonary - drug therapy | Bacterial Infections - virology | Liver - drug effects | Autopsy | HIV Infections - mortality | Lymph Nodes - drug effects | Bacterial Infections - microbiology | Bone Marrow - drug effects | Bone Marrow - virology | Kidney - drug effects | Bacterial Infections - drug therapy | HIV Infections - virology | Tuberculosis, Pulmonary - pathology | Tuberculosis, Pulmonary - mortality | Bacterial Infections - pathology | Lung - drug effects | Biopsy, Needle | Kidney - virology | Bacterial Infections - mortality | Mycobacterium tuberculosis - growth & development | Lymph Nodes - pathology | Mycobacterium tuberculosis - drug effects | Cause of Death | HIV - drug effects | Lung - virology | Immune Reconstitution Inflammatory Syndrome - virology | HIV Infections - pathology | Adult | Female | Skin - virology | Skin - pathology | Lung - pathology | South Africa - epidemiology | Lymph Nodes - virology | Immune Reconstitution Inflammatory Syndrome - mortality | HIV - growth & development | Antiretroviral Therapy, Highly Active | Immune Reconstitution Inflammatory Syndrome - pathology | Bone Marrow - pathology | Immune Reconstitution Inflammatory Syndrome - drug therapy | HIV Infections - drug therapy | Skin - drug effects | Tuberculosis, Pulmonary - virology | Antiviral agents | Bacterial infections | Mycobacterium tuberculosis | Dosage and administration | Diagnosis | Research | Drug therapy | Risk factors | Reproductive health | Health sciences | Therapy | Laboratories | Liver | Systematic review | Infections | Cerebrospinal fluid | Drug resistance | Lymph nodes | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Bone marrow | Bacteria | Ultrasound | Spleen | Autopsies | Kidneys | Internal medicine | Mortality | Immune reconstitution | Inflammation | Patients | Antiretroviral therapy | Medicine | Hospitals | Tuberculosis | Infectious diseases | Lungs | Biopsy | Death | Fatalities | Adults | Skin | Bone | Kidney transplantation | Lymph | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9776, pp. 1495 - 1505
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 7, pp. 563 - 571
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 8, p. e24215
Journal Article
The Journal of Immunology, ISSN 0022-1767, 11/2004, Volume 173, Issue 10, pp. 6357 - 6365
Bacillus Calmette-Guerin (BCG) vaccine has failed to control the global tuberculosis (TB) epidemic, and there is a lack of safe and effective mucosal vaccines... 
MYCOBACTERIUM-TUBERCULOSIS | ENHANCED IMMUNOGENICITY | IMMUNITY | DNA VACCINES | EFFICACY | SYSTEMIC IMMUNIZATION | CD4(+) T-CELLS | RECENT PROGRESS | INFECTION | IMMUNOLOGY | BCG VACCINES | Vaccines, DNA - genetics | Mycobacterium bovis - immunology | Viral Vaccines - genetics | Mycobacterium tuberculosis - immunology | Vaccines, DNA - immunology | Respiratory Mucosa - virology | Vaccines, Synthetic - immunology | Acyltransferases - genetics | Antigens, Bacterial - biosynthesis | Antigens, Bacterial - genetics | Vaccines, DNA - administration & dosage | Acyltransferases - biosynthesis | CD4-Positive T-Lymphocytes - immunology | Respiratory Mucosa - microbiology | Immunization, Secondary | Injections, Subcutaneous | Respiratory Mucosa - immunology | Adenoviridae - genetics | Female | Tuberculosis Vaccines - immunology | Adenoviridae - immunology | Tuberculosis Vaccines - genetics | Immunity, Cellular - genetics | Tuberculosis Vaccines - administration & dosage | Vaccines, Synthetic - genetics | Injections, Intramuscular | Administration, Intranasal | Tuberculosis, Pulmonary - prevention & control | Viral Vaccines - administration & dosage | Tuberculosis, Pulmonary - immunology | Animals | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Genetic Vectors | Viral Vaccines - immunology | Mycobacterium tuberculosis - genetics | Tuberculosis, Pulmonary - virology
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue suppl_2, pp. S171 - S178
Background. Delayed diagnosis of tuberculosis (TB) and drug-resistant TB are major challenges of TB control in Thailand. This study assessed the practicality... 
Mycobacteria growth indicator tube (MGIT) | HIV/TB coinfection | Pulmonary tuberculosis | Rifampicin-resistance tuberculosis | DIAGNOSIS | INFECTIOUS DISEASES | TREATMENT OUTCOMES | TUBERCULOSIS | RIFAMPIN | MICROBIOLOGY | IMMUNOLOGY | mycobacteria growth indicator tube (MGIT) | pulmonary tuberculosis | CULTURE-SYSTEM | rifampicin-resistance tuberculosis | RESISTANCE | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Molecular Diagnostic Techniques - methods | Tuberculosis, Multidrug-Resistant - virology | Prevalence | Prospective Studies | HIV Infections - epidemiology | Humans | Middle Aged | Male | Molecular Diagnostic Techniques - economics | Thailand | Mycobacterium tuberculosis - drug effects | Tuberculosis, Multidrug-Resistant - diagnosis | HIV Infections - microbiology | Tuberculosis, Multidrug-Resistant - microbiology | HIV Infections - diagnosis | Sensitivity and Specificity | Adult | Female | Tertiary Care Centers | HIV Infections - virology | Molecular Diagnostic Techniques - instrumentation | Bacterial Proteins - genetics | DNA-Directed RNA Polymerases - genetics | Coinfection - epidemiology | Coinfection - virology | Tuberculosis, Multidrug-Resistant - epidemiology | Mycobacterium tuberculosis - isolation & purification | Coinfection - microbiology | Tuberculosis, Pulmonary - diagnosis | Coinfection - diagnosis | Tuberculosis, Pulmonary - epidemiology | Rifampin - pharmacology | Delayed Diagnosis - prevention & control | Mycobacterium tuberculosis - genetics | Mycobacterium tuberculosis - growth & development | Tuberculosis, Pulmonary - virology | Centrifugation | Staining | Immune reconstitution | Viruses | Infections | Drug resistance | Medical diagnosis | Disease control | Patients | Gene sequencing | Sensitivity | Tuberculosis | Human immunodeficiency virus--HIV | Sputum | RpoB protein | Smear | Clinical medicine | Diagnosis | Rifampin | Culture
Journal Article
PLoS Pathogens, ISSN 1553-7366, 07/2013, Volume 9, Issue 7, p. e1003468
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2018, Volume 62, Issue 2
Lopinavir-ritonavir forms the backbone of current first-line antiretroviral regimens in young HIV-infected children. As multidrug-resistant (MDR) tuberculosis... 
Population pharmacokinetics | Mycobacterium tuberculosis | Antiretroviral agents | Drug interactions | Multidrug resistance | Pediatric infectious disease | Pediatric drug therapy | Human immunodeficiency virus | Pharmacokinetics | Anti-HIV Agents - pharmacology | Tuberculosis, Pulmonary - microbiology | Tuberculosis, Multidrug-Resistant - virology | Lopinavir - blood | Humans | Male | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | HIV - drug effects | Lopinavir - pharmacokinetics | Tuberculosis, Pulmonary - blood | HIV Infections - microbiology | Drug Interactions | Tuberculosis, Multidrug-Resistant - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Ritonavir - pharmacology | Anti-HIV Agents - blood | Ethambutol - therapeutic use | Child | Antitubercular Agents - therapeutic use | HIV Infections - blood | Lopinavir - pharmacology | Drug Administration Schedule | Ritonavir - blood | HIV Infections - virology | Models, Statistical | Pyrazinamide - therapeutic use | HIV - growth & development | Ritonavir - pharmacokinetics | Anti-HIV Agents - pharmacokinetics | HIV Infections - drug therapy | Tuberculosis, Multidrug-Resistant - blood | Drug Combinations | Mycobacterium tuberculosis - growth & development | Tuberculosis, Multidrug-Resistant - drug therapy | Tuberculosis, Pulmonary - virology
Journal Article